A new model to prevent mother-to-child HIV transmission in Malawi
Official title: UNCPM 22401 - Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model for the Elimination of Mother-to-Child Transmission of HIV in Lilongwe and Mangochi, Malawi
Run by University of North Carolina, Chapel Hill · NCT06493357 · Data updated 2026-11-12
This study is testing a new community-based approach called the PAC-Man model to see if it can better prevent the spread of HIV from mothers to their babies in Malawi compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 2426 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 3 sites (Lilongwe, Central Region and 2 other locations) |
| Status | Recruiting |
| Started | March 27, 2025 |
| Main results expected | March 31, 2028 |
| Study ends | March 31, 2028 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT06493357 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pregnant and breastfeeding women living with HIV who are enrolled in the national elimination of mother-to-child transmission program.
✕Probably not a fit
Patients who are not enrolled in the national EMTCT program or those who have previously participated in the field survey may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the PAC-Man model, an integrated approach to eliminate mother-to-child transmission of HIV by providing community-based services. It compares the effectiveness of this model against standard care in ensuring timely early infant diagnosis testing and maternal viral load testing for pregnant and breastfeeding women living with HIV. The study involves a large sample of mother-infant pairs, health providers, and policymakers to assess both clinical outcomes and implementation strategies. The PAC-Man model utilizes mobile care teams equipped with advanced diagnostic technology to reach high-risk populations.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the rates of HIV transmission from mothers to infants in Malawi.
How similar studies have gone: Other studies have shown success with community-based interventions for HIV prevention, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
The criteria for Enumerated MIP Cohort is as follows: Inclusion Criteria: * Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey. Exclusion Criteria: * None. The criteria for Enumerated MIP Field Survey is as follows: Inclusion Criteria: * Age 16 years or older. * Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey. Exclusion Criteria: * Documented transferred out from a site prior to the field survey. * Participated previously in the field survey. * Decline informed consent. The criteria for In-Depth Interviews is as follows: Inclusion criteria: * Age 16 years or older. * Met high-risk criteria for PAC-Man model. * Participated in a field survey. Exclusion criteria: * Decline informed consent. The criteria for Focus Group Discussions is as follows: Inclusion criteria: * Age 18 years or older. * MOH or implementing partner professional or lay health worker at a study site (such as nurses, community health workers, health surveillance assistants, and HIV diagnostic assistants) * Generally familiar with the PAC-Man model and/or EMTCT/ EID service delivery at their site. Exclusion criteria: * Decline informed consent. The criteria for Key Informant Interviews is as follows: Inclusion criteria: * Age 18 years or older. * HIV/ EMTCT policy maker OR MOH/ PEPFAR implementing partner senior manager. * Generally familiar with HIV and/or EMTCT/ EID service delivery. Exclusion criteria: * Decline informed consent. The criteria for Implementation Actor Questionnaires is as follows: Inclusion criteria: * Age 18 years or older. * Professional or lay health provider at a study site. * Generally familiar with HIV and/or EMTCT/ EID service delivery at their site. * Participated in a focus group discussion. Exclusion criteria: * Decline informed consent.
Where it's running
-
Area 18 Health Centre
Lilongwe, Malawi Recruiting -
Monkey Bay Community Hospital
Monkey Bay, Malawi Recruiting -
Bwaila Hospital
Lilongwe, Central Region, Malawi Not yet recruiting
Study contacts
- Principal investigator: Michael Herce, MD, MPH — University of North Carolina, Chapel Hill
- Study coordinator: Michael Herce, MD, MPH
- Email: michael_herce@med.unc.edu
- Phone: 9198435996
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pharmacist-guided PEP/PrEP Access Using PEPPI Software
This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.
-
Feasibility of Online HIV Prevention Research for People Who Inject Drugs
This study tests whether online recruitment and at-home HIV testing can be done reliably by and for people who inject drugs.
-
Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok
This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.
-
Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok
This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.
-
See if PrEP Choice helps young people start and stick with HIV prevention methods
This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.
-
Adding sexual-pleasure conversations to harm reduction services for MSM and transgender people who do chemsex in Thailand
This project will try using a 'Pleasuremeter' to guide sexual-pleasure conversations in harm reduction services for MSM and transgender people who engage in chemsex or substance use in Thailand to see if it improves sexual health, substance use, and related outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.